Recipharm, a Swedish contract development and manufacturing organization, has equipped its facility in Lisbon, Portugal with serialization capabilities ahead of US and European regulation enforcement deadlines.

The facility is the latest of Recipharm’s facilities to be prepared to start supplying serialized products to the US and Europe following a EUR 40 million ($46.9 million) investment into its company-wide implementation program in 2016. In February 2016, Recipharm announced that it would invest over the following three years to provide solutions for the serialization processes.

Recipharm has delivered more than1.3 million serialized and aggregated packs to markets, such as China, South Korea, Saudi Arabia, and Turkey, where serialization regulations are currently in place. The Lisbon site is the company’s sixth site to become serialization-ready for the US and European markets and adds an additional four packaging lines to the company’s current serialization capabilities. These lines will be followed by a further seven lines at the facility by the second quarter of 2018.

The next site to be equipped will be the company’s facility in Brescia, Italy, which will supply serialized product to the US.  

Source: Recipharm